Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Pharmazz announced it raised $250,000 in an initial filing from an offering of $3.5 Million

PRIVATEJul 28, 202612 days ago

Amount Raised

$250,000

Round Type

Venture - Series Unknown

WillowbrookBiotechnologyHealthcareHealth Care

Company Information

Company

Pharmazz

Location

50 W 75TH ST

Willowbrook, Illinois, United States

About

Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke. In addition, Pharmazz obtained marketing authorization for two of its first-in-class drug molecules, Centhaquine and Sovateltide, for hypovolemic shock and ischemic stroke, respectively, in India. Pharmazz has partnered with Sun Pharmaceutical to market Sovateltide for cerebral ischemic stroke patients in India. In addition, Pharmazz has partnered with Dr. Reddy's Laboratories to market Centhaquine, a resuscitative agent, in India.

Related People

Suggested for you
3 contacts
Verified contactsManish, Managing Director hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Pharmazz's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.